Ocular adverse effects of common psychotropic agents: a review.
Richa S, Yazbek JC.
CNS Drugs. 2010 Jun;24(6):501-26. doi: 10.2165/11533180-000000000-00000.
Fuchs endothelial corneal dystrophy and corneal endothelial diseases: East meets West.
Soh YQ, Kocaba V, Pinto M, Mehta JS.
Eye (Lond). 2020 Mar;34(3):427-441. doi: 10.1038/s41433-019-0497-9. Epub 2019 Jul 2.
Bietti Crystalline Dystrophy.
Vargas M, Mitchell A, Yang P, Weleber R.
2012 Apr 12 [updated 2019 Feb 7]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Exfoliation syndrome.
Ritch R, Schlötzer-Schrehardt U.
Surv Ophthalmol. 2001 Jan-Feb;45(4):265-315. doi: 10.1016/s0039-6257(00)00196-x.
Heterochromia.
Lui F, Stokkermans TJ.
2023 Jun 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Pigment Dispersion Syndrome.
Gurnani B, Kaur K.
2023 Jun 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Pigment Dispersion Glaucoma.
Zeppieri M, Tripathy K.
2023 Aug 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
[Pigment Dispersion Syndrome].
Nobl M, Mackert M.
Klin Monbl Augenheilkd. 2021 Apr 19. doi: 10.1055/a-1472-0471. Online ahead of print.
Pigment dispersion syndrome: A brief overview.
Zeppieri M.
J Clin Transl Res. 2022 Sep 7;8(5):344-350. eCollection 2022 Oct 31.
Chlorpromazine-induced skin pigmentation with corneal and lens opacities.
Huff LS, Prado R, Pederson JF, Dunnick CA, Lucas LM.
Cutis. 2014 May;93(5):247-50.
